Palisade Capital Management LP Has $3.03 Million Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Palisade Capital Management LP boosted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 16.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 44,163 shares of the company's stock after purchasing an additional 6,304 shares during the quarter. Palisade Capital Management LP's holdings in Henry Schein were worth $3,025,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Invesco Ltd. raised its position in shares of Henry Schein by 0.4% during the fourth quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock valued at $343,468,000 after buying an additional 17,552 shares during the last quarter. FMR LLC increased its stake in Henry Schein by 6.6% during the fourth quarter. FMR LLC now owns 3,498,033 shares of the company's stock valued at $242,064,000 after acquiring an additional 217,143 shares during the period. Geode Capital Management LLC raised its holdings in Henry Schein by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock valued at $218,762,000 after acquiring an additional 14,876 shares in the last quarter. Palestra Capital Management LLC bought a new stake in shares of Henry Schein in the 4th quarter worth approximately $182,988,000. Finally, Fiduciary Management Inc. WI grew its holdings in shares of Henry Schein by 7.2% during the 4th quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company's stock worth $172,193,000 after purchasing an additional 167,990 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Trading Up 0.2%

Shares of NASDAQ HSIC traded up $0.19 during mid-day trading on Friday, hitting $74.67. The company's stock had a trading volume of 699,008 shares, compared to its average volume of 1,721,443. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The company's fifty day simple moving average is $70.51 and its 200-day simple moving average is $71.17. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.38 and a quick ratio of 0.75. The stock has a market cap of $9.09 billion, a price-to-earnings ratio of 23.33, a price-to-earnings-growth ratio of 2.40 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The business's quarterly revenue was down .1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.10 EPS. On average, sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently commented on HSIC shares. Piper Sandler cut their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. Barrington Research reduced their price objective on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a report on Tuesday, May 6th. Wells Fargo & Company decreased their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Finally, Wall Street Zen lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $79.30.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.